Cargando…

Mutation spectrum of Egyptian children with cystic fibrosis

OBJECTIVE: To know the common CFTR mutations in the Egyptian patients with cystic fibrosis as it was previously thought to be uncommon disease in Egypt. METHODS: This is a cross sectional study of 60 patients diagnosed as cystic fibrosis by sweat chloride testing. They were enrolled from the Allergy...

Descripción completa

Detalles Bibliográficos
Autores principales: Shahin, Walaa Aboulkasem, Mehaney, Dina Ahmed, El-Falaki, Mona Mostafa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4899348/
https://www.ncbi.nlm.nih.gov/pubmed/27347467
http://dx.doi.org/10.1186/s40064-016-2338-7
_version_ 1782436446214291456
author Shahin, Walaa Aboulkasem
Mehaney, Dina Ahmed
El-Falaki, Mona Mostafa
author_facet Shahin, Walaa Aboulkasem
Mehaney, Dina Ahmed
El-Falaki, Mona Mostafa
author_sort Shahin, Walaa Aboulkasem
collection PubMed
description OBJECTIVE: To know the common CFTR mutations in the Egyptian patients with cystic fibrosis as it was previously thought to be uncommon disease in Egypt. METHODS: This is a cross sectional study of 60 patients diagnosed as cystic fibrosis by sweat chloride testing. They were enrolled from the Allergy and Pulmonology Unit Children’s Hospital Cairo University. They were screened for the presence of the frequent 36 mutations in Caucasians by reverse hybridization line probe technique, using INNO-LiPACFTR19 and CFTR17 + Tn kits. RESULTS: Most of patients presented with classic manifestations of CF such as variable pulmonary disease and pancreatic insufficiency, and hepatomegaly with or without ascites. The mutations detected were F508 del (58 %), 2183AA/G (10 %), N1303K (6 %), I148T (4 %), W1282X (4 %), G155D (2 %), CFTRdel2-3 (21 KB) (2 %), 3199del6 (2 %), R347P (2 %). Unique to the Egyptian population are these mutations R1162X and A544E (6, 4 %) respectively they were found in our cohort study and were not reported elsewhere in the Arab population till now. There was no association between the initial clinical presentation of CF and the genotypes detected. CONCLUSION: The F508 del is still the most commonly encountered mutation (58 %), however other rare mutations were identified where each ranged from (2 to 10 %).
format Online
Article
Text
id pubmed-4899348
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-48993482016-06-24 Mutation spectrum of Egyptian children with cystic fibrosis Shahin, Walaa Aboulkasem Mehaney, Dina Ahmed El-Falaki, Mona Mostafa Springerplus Research OBJECTIVE: To know the common CFTR mutations in the Egyptian patients with cystic fibrosis as it was previously thought to be uncommon disease in Egypt. METHODS: This is a cross sectional study of 60 patients diagnosed as cystic fibrosis by sweat chloride testing. They were enrolled from the Allergy and Pulmonology Unit Children’s Hospital Cairo University. They were screened for the presence of the frequent 36 mutations in Caucasians by reverse hybridization line probe technique, using INNO-LiPACFTR19 and CFTR17 + Tn kits. RESULTS: Most of patients presented with classic manifestations of CF such as variable pulmonary disease and pancreatic insufficiency, and hepatomegaly with or without ascites. The mutations detected were F508 del (58 %), 2183AA/G (10 %), N1303K (6 %), I148T (4 %), W1282X (4 %), G155D (2 %), CFTRdel2-3 (21 KB) (2 %), 3199del6 (2 %), R347P (2 %). Unique to the Egyptian population are these mutations R1162X and A544E (6, 4 %) respectively they were found in our cohort study and were not reported elsewhere in the Arab population till now. There was no association between the initial clinical presentation of CF and the genotypes detected. CONCLUSION: The F508 del is still the most commonly encountered mutation (58 %), however other rare mutations were identified where each ranged from (2 to 10 %). Springer International Publishing 2016-05-20 /pmc/articles/PMC4899348/ /pubmed/27347467 http://dx.doi.org/10.1186/s40064-016-2338-7 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Research
Shahin, Walaa Aboulkasem
Mehaney, Dina Ahmed
El-Falaki, Mona Mostafa
Mutation spectrum of Egyptian children with cystic fibrosis
title Mutation spectrum of Egyptian children with cystic fibrosis
title_full Mutation spectrum of Egyptian children with cystic fibrosis
title_fullStr Mutation spectrum of Egyptian children with cystic fibrosis
title_full_unstemmed Mutation spectrum of Egyptian children with cystic fibrosis
title_short Mutation spectrum of Egyptian children with cystic fibrosis
title_sort mutation spectrum of egyptian children with cystic fibrosis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4899348/
https://www.ncbi.nlm.nih.gov/pubmed/27347467
http://dx.doi.org/10.1186/s40064-016-2338-7
work_keys_str_mv AT shahinwalaaaboulkasem mutationspectrumofegyptianchildrenwithcysticfibrosis
AT mehaneydinaahmed mutationspectrumofegyptianchildrenwithcysticfibrosis
AT elfalakimonamostafa mutationspectrumofegyptianchildrenwithcysticfibrosis